Literature DB >> 22391983

The emerging of xylazine as a new drug of abuse and its health consequences among drug users in Puerto Rico.

J C Reyes1, J L Negrón, H M Colón, A M Padilla, M Y Millán, T D Matos, R R Robles.   

Abstract

During the last decade, the veterinary anesthetics have gained popularity as recreational drugs. The aim of this study was to document the use of "anestecia de caballo" (xylazine) and its consequences among drug users in Puerto Rico. The study combined a cross-sectional survey with 89 drug users and two focus groups conducted in Mayagüez with frontline drug treatment providers. Drug users were recruited from communities of the San Juan metropolitan area using a variety of ethnographic and outreach strategies. A short questionnaire developed for the study collected information on sociodemographics, xylazine use, and its consequences. The two focus groups were conducted to discuss the details related to xylazine use, its consequences, and utilization awareness. The sample comprised 63 males (70.8%) and 26 females with a mean age of 37.2 years. The mean number of years of drug use was 14.3, with a mean frequency of drug use of 5.9 times daily. More than 65% reported speedball as the principal drug of use. The prevalence of xylazine use was 80.7%. More than 42% of the sample used xylazine in a mixture with speedball. The main route of administration of xylazine was injection but 14% reported the use of xylazine by inhalation. More than 35% of the sample reported skin lesions and 21.1% reported at least one overdose episode. Multiple logistic regression analysis revealed that males (OR = 3.47, CI = 1.10-12.00) and those who reported speedball as their main drug of use (OR = 9.34, CI = 2.51-34.70) were significantly more likely to be xylazine users. Focus groups revealed that drug users claimed to recognize the presence of xylaxine in a mixture of speedball based on its effects, taste, the color of the drug (dark brown), and its odor. In conclusion, the use of xylazine among drug users in Puerto Rico seems to be an emerging trend with potentially serious health consequences.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22391983      PMCID: PMC3368046          DOI: 10.1007/s11524-011-9662-6

Source DB:  PubMed          Journal:  J Urban Health        ISSN: 1099-3460            Impact factor:   3.671


  16 in total

Review 1.  Severe intoxication from xylazine inhalation.

Authors:  A J Capraro; J F Wiley; J R Tucker
Journal:  Pediatr Emerg Care       Date:  2001-12       Impact factor: 1.454

2.  A reported case involving impaired driving following self-administration of xylazine.

Authors:  Matthew E Stillwell
Journal:  Forensic Sci Int       Date:  2003-06-24       Impact factor: 2.395

3.  Influence of different anesthetics on skin oxygenation studied by electron paramagnetic resonance in vivo.

Authors:  Z Abramovic; M Sentjurc; J Kristl; N Khan; H Hou; H M Swartz
Journal:  Skin Pharmacol Physiol       Date:  2006-12-01       Impact factor: 3.479

4.  Solid-phase extraction and gas chromatographic- mass spectrometric determination of the veterinary drug xylazine in human blood.

Authors:  M Barroso; E Gallardo; C Margalho; N Devesa; J Pimentel; D N Vieira
Journal:  J Anal Toxicol       Date:  2007-04       Impact factor: 3.367

5.  Xylazine abuse: a rare cause of syncope.

Authors:  Chang-Ming Liu; Ming-Jang Chiu; Cheng-Chung Fang; Wen-Jone Chen
Journal:  Clin Toxicol (Phila)       Date:  2007       Impact factor: 4.467

6.  Racial disparities in mental health service use by adolescents who thought about or attempted suicide.

Authors:  Stacey Freedenthal
Journal:  Suicide Life Threat Behav       Date:  2007-02

7.  Heroin: what's in the mix?

Authors:  Allison A Muller; Kevin C Osterhoudt; William Wingert
Journal:  Ann Emerg Med       Date:  2007-09       Impact factor: 5.721

8.  Behavioral risk factors and human immunodeficiency virus (HIV) prevalence among intravenous drug users in Puerto Rico.

Authors:  R R Robles; H M Colón; H Sahai; T D Matos; C A Marrero; J C Reyes
Journal:  Am J Epidemiol       Date:  1992-03-01       Impact factor: 4.897

9.  Inhalant use and suicidality among incarcerated youth.

Authors:  Stacey Freedenthal; Michael G Vaughn; Jeffrey M Jenson; Matthew O Howard
Journal:  Drug Alcohol Depend       Date:  2007-04-11       Impact factor: 4.492

10.  Challenges in assessing intent to die: can suicide attempters be trusted?

Authors:  Stacey Freedenthal
Journal:  Omega (Westport)       Date:  2007
View more
  11 in total

Review 1.  Is it prime time for alpha2-adrenocepter agonists in the treatment of withdrawal syndromes?

Authors:  Timothy E Albertson; James Chenoweth; Jonathan Ford; Kelly Owen; Mark E Sutter
Journal:  J Med Toxicol       Date:  2014-12

2.  Anesthesia-inducing drugs also induce conditioned taste aversions.

Authors:  Jian-You Lin; Joe Arthurs; Steve Reilly
Journal:  Physiol Behav       Date:  2017-05-09

3.  Xylazine spreads across the US: A growing component of the increasingly synthetic and polysubstance overdose crisis.

Authors:  Joseph Friedman; Fernando Montero; Phillippe Bourgois; Rafik Wahbi; Daniel Dye; David Goodman-Meza; Chelsea Shover
Journal:  Drug Alcohol Depend       Date:  2022-02-26       Impact factor: 4.852

4.  Trends in the Distribution of Opioids in Puerto Rico, 1999-2013.

Authors:  Sausan El Burai Félix; Karin A Mack; Christopher M Jones
Journal:  P R Health Sci J       Date:  2016-09       Impact factor: 0.705

5.  Addressing the HIV/AIDS epidemic among Puerto Rican people who inject drugs: the need for a multiregion approach.

Authors:  Sherry Deren; Camila Gelpí-Acosta; Carmen E Albizu-García; Ángel González; Don C Des Jarlais; Salvador Santiago-Negrón
Journal:  Am J Public Health       Date:  2014-09-11       Impact factor: 9.308

6.  Toxic effects of xylazine on endothelial cells in combination with cocaine and 6-monoacetylmorphine.

Authors:  L A Silva-Torres; C Vélez; J Lyvia Alvarez; J G Ortiz; B Zayas
Journal:  Toxicol In Vitro       Date:  2014-07-08       Impact factor: 3.500

7.  When "the Cure" Is the Risk: Understanding How Substance Use Affects HIV and HCV in a Layered Risk Environment in San Juan, Puerto Rico.

Authors:  Diana Hernández; Pedro C Castellón; Yohansa Fernández; Francisco A Torres-Cardona; Carrigan Parish; Danielle Gorshein; Jose Vargas Vidot; Sandra Miranda de Leon; Allan Rodriguez; Jorge Santana Bagur; Daniel J Feaster; Bruce R Schackman; Lisa R Metsch
Journal:  Health Educ Behav       Date:  2017-09-09

8.  Xylazine as a drug of abuse and its effects on the generation of reactive species and DNA damage on human umbilical vein endothelial cells.

Authors:  Luz Silva-Torres; Christian Veléz; Lyvia Alvarez; Beatriz Zayas
Journal:  J Toxicol       Date:  2014-11-11

9.  Xylazine-induced reduction of tissue sensitivity to insulin leads to acute hyperglycemia in diabetic and normoglycemic monkeys.

Authors:  Yong-Fu Xiao; Bingdi Wang; Xiaoli Wang; Fenglai Du; Michael Benzinou; Yi-Xin Jim Wang
Journal:  BMC Anesthesiol       Date:  2013-10-20       Impact factor: 2.217

10.  Invited Commentary: Drug Checking for Novel Insights Into the Unregulated Drug Supply.

Authors:  Nabarun Dasgupta; Mary C Figgatt
Journal:  Am J Epidemiol       Date:  2022-01-24       Impact factor: 4.897

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.